Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Guerbet Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (79)
Cancellation by sponsor (32)
Prescription medicine registration (3)
Section 14, TGO91 consent (3)

Date

2025 (32)
2023 (3)
2022 (2)
2021 (7)
2020 (8)
2019 (4)
2018 (8)
2017 (8)
2016 (8)
2015 (1)
2014 (1)
2013 (1)
2010 (3)
2004 (1)
2003 (3)
2000 (5)
1999 (1)
1997 (2)
1995 (2)
1994 (12)
1993 (2)
1991 (3)

Search

Sponsor content

117 result(s) found, displaying 21 to 30

ELUCIREM gadopiclenol 24.26 mg/50 mL injection solution vial (444262)

22 April 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ELUCIREM gadopiclenol 24.26 mg/50 mL injection solution vial.
ELUCIREM gadopiclenol 7.28 mg/15 mL injection solution prefilled syringe (444290)

22 April 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ELUCIREM gadopiclenol 7.28 mg/15 mL injection solution prefilled syringe.
Guerbet Australia Pty Ltd - Intravascular microflow catheter Cancelled under Section 41GL(d) of the Act

13 June 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd - Radiographic procedure tubing Cancelled under Section 41GL(d) of the Act

13 June 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd - Radiographic procedure tubing Cancelled under Section 41GL(d) of the Act

13 June 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd - CT9000 ADV Injection System with or without Optibolus - Contrast medium injector system, powered, multi-phase Cancelled under Section 41GL(d) of the Act

13 June 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd Tubing, radiographic procedure Cancelled under Section 41GL(d) of the Act

13 June 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
OPTIRAY 240 Ioversol 25.45 g/50 mL injection vial Cancelled under Section 30(1)(c) of the Act

15 April 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
OPTIRAY 240 Ioversol 63.63 g/125 mL injection syringe (power injector) Cancelled under Section 30(1)(c) of the Act

15 April 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
OPTIRAY 240 Ioversol 25.45/50mL injection syringe (hand held) Cancelled under Section 30(1)(c) of the Act

15 April 2025

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.